Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

View:
Post by Red~One on Feb 11, 2022 9:52pm

Sorry Donrun

Yes, absolutely, the health benefits of properly delivered N.O. are becoming more apparent every day. The main stumbling block in the last 2 decades  has been , safe delivery. How to get it safely  to that part of the body without any early release or cytotoxic or neurotoxic effects. Recent studies , especially from overseas have shown many alternative delivery systems that are safe, but need more testing. It is happening now. Kind of exciting times. N.O. will be front page news soon. Nice to be onboard, eh?
Comment by SeeDonRun on Feb 11, 2022 10:07pm
Agreed, it is nice to be onboard.  What I really like about Clas in this respect is the depot effect and the ability to make NO without having to use gas or combine two substances with each use.  If it's safe and works as good in humans as it does in animals then it will be way ahead of the curve on the NO front for sure.  Anyhow, what are the two NO stocks you are inveted in? ...more  
Comment by Red~One on Feb 11, 2022 10:17pm
don't think it means all that much to be ahead of the curve, I mean there are lots of sick people out there, I mean look at China, population 1.4 Billion....should't have to worry about your stock, hopefully....lotsa sick people  for ya
Comment by SeeDonRun on Feb 11, 2022 10:29pm
I think it would be way ahead of the curve if the science works.  Depot action means less times you have to apply it and combined with it being liquid rather than gas means less equipment and professional staff to administer it which opens up the entire third world to help and save lives in.  A lot of places that don't have the money to be treated even if they could get to hospitals ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities